|
|
Effect of First Prescription for Hemorrhagic Stroke on the brain tissue of rats with intracerebral hemorrhage |
ZHANG Jie1 WU Qian1 WANG Xiaoling2 TANG Yong2 WU Zongtao2 |
1.Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang 712046, China;
2.Ankang Hospital of Traditional Chinese Medicine, Shaanxi Province, Ankang 725000, China |
|
|
Abstract Objective To study the effect of First Prescription for Hemorrhagic Stroke on the brain tissue of rats with intracerebral hemorrhage (ICH). Methods A total of 84 male SD rats with the body weight of (220±20) g were randomly selected and divided into blank group and sham operation group (injected with normal saline) by random number table method, with 12 rats in each group. The remaining 60 rats were treated with ICH model induced by collagase Ⅶ injection, and were divided into model group, Naoxueshu group (2.08 ml/kg), and First Prescription for Hemorrhagic Stroke low-dose, medium-dose, and high-dose groups (3.2, 6.4, 12.8 g/kg) by random number table method. Blank group, sham operation group, and model group were intragastric with equal amount of normal saline, and the other groups were intragastric with corresponding dose of drugs, once a day, for consecutive seven days. After administration, hematoxylin-eosin staining was used to observe the pathological changes of seven groups. The changes of cerebral water content in seven groups were determined by wet and dry weight method. The levels of tumor necrosis factor -α (TNF-α) and interleukin-6 (IL-6) in the seven groups were detected by enzyme linked immunosorbent assay, and the levels of nuclear factor-κB (NB-κB) p65 and phosphorylated NF-κB (p-NF-κB) p65 were detected by Western blot. Results The blank group and the sham operation group had complete brain tissue structure, the model group had a large number of red blood cells and inflammatory cells infiltration, disorder, severe edema, First Prescription for Hemorrhagic Stroke low-dose, medium-dose, and high-dose groups all had a small number of red blood cells. There were no significant differences in cerebral water content, TNF-α, IL-6, and p-NF-κB p65 levels between blank group and sham group (P > 0.05). The cerebral water content, TNF-α, IL-6, and p-NF-κB p65 in model group were higher than those in blank group (P < 0.05). The cerebral water content, TNF-α, IL-6, and p-NF-κB p65 in First Prescription for Hemorrhagic Stroke medium-dose and high-dose groups were lower than those in the model group and First Prescription for Hemorrhagic Stroke low-dose group (P < 0.05). There were no significant differences in cerebral water content, TNF-α, IL-6, and p-NF-κB p65 levels between First Prescription for Hemorrhagic Stroke low-dose group and model group (P > 0.05). There was no significant difference in cerebral water content, TNF-α, IL-6, and p-NF-κB p65 between Hemorrhagic Stroke medium-dose and high-dose groups (P > 0.05). There was no significant difference in NF-κB p65 level among all groups (P > 0.05). Conclusion Medium and high dose of First Prescription for Hemorrhagic Stroke has brain protective effect on ICH rats, which may be related to the inhibition of p-NF-κB P65, TNF-α, and IL-6 expression.
|
|
|
|
|
[1] 孙海欣,王文志.中国60万人群脑血管病流行病学抽样调查报告[J].中国现代神经疾病杂志,2018,18(2):83-88.
[2] 倪小佳,陈耀龙,蔡业峰.中西医结合脑卒中循证实践指南(2019)[J].中国循证医学杂志,2020,20(8):901-912.
[3] 张超,王晓玲,潘平康,等.出血性中风1、2号方对出血性中风患者的神经保护机制研究[J].系统医学,2020,6(1):3-4.
[4] 唐勇,王晓玲,熊海涛,等.出血性中风中西医结合序贯优化方案再评价及多中心临床观察[J].贵州医药,2020, 44(4):555-557.
[5] 王晓玲,唐勇,张展峰,等.中西医结合序贯方案治疗出血性中风56例疗效观察[J].中医杂志,2012,53(10):857-859.
[6] 李东方,赵海滨,姜天元,等.采用Ⅶ型胶原酶制作大鼠脑出血模型的技巧[J].神经药理学报,2015,5(4):22-25.
[7] 毕红东,江思瑜,李宝群,等.补阳还五汤对脑出血大鼠脑组织HIF-1α、SDF-1、CXCR-4表达的影响[J].中国老年学杂志,2021,41(17):3755-3758.
[8] 杨国福,金坤林,张志君.实验卒中模型方法学[M].上海:上海交通大学出版社,2019.
[9] 王哲,刘震,刘昕,等.两种实验性大鼠脑出血模型的对比研究[J].第三军医大学学报,2016,38(13):1494-1500.
[10] 范学政,游潮.国内高血压脑出血微创血肿清除手术治疗现状及趋势[J].中华神经医学杂志,2017,16(9):956-961.
[11] 李婷婷,盛蕾,过伟峰,等.基于病机证素组合的出血性中风急性期证候诊断[J].中华中医药杂志,2016,31(2):714-717.
[12] 院立新,陈澈,张根明,等.活血化瘀治疗对脑出血患者预后的影响[J].中国中西医结合杂志,2015,35(2):174-178.
[13] 王若男,赵德喜.应用活血化瘀法治疗脑出血研究进展[J].辽宁中医杂志,2021,48(6):235-237.
[14] 赵凤鸣,黄艳,吴铭杰,等.出血性中风瘀热证患者炎症因子表达及其临床意义[J].中华中医药杂志,2018,33(12):5705-5707.
[15] 吴倩,王晓玲,唐勇,等.自拟出血性中风1号方治疗脑出血作用靶点的筛选及其生物学功能分析[J].山东医药,2021,61(3):37-42.
[16] 靳娜,张国华.脑出血后脑水肿的形成机制及治疗进展[J].医学综述,2017,23(12):2380-2384.
[17] 濮璟楠,师蔚.脑出血后脑水肿管理专家共识[J].实用心脑肺血管病杂志,2017,25(8):1-6.
[18] 吴冬梅,赵旭,汪坤,等.大黄对脑出血大鼠的脑保护作用[J].郑州大学学报(医学版),2021,56(2):258-265.
[19] 卢金凤,向靓,黄薇,等.栀子总环烯醚萜苷对脑出血大鼠内皮屏障的影响[J].中药药理与临床,2012,28(3):48-51.
[20] 荣玉婷,汤其强,任明山.急性脑出血患者血清炎症因子和C-反应蛋白的动态监测及在病情恶化中的预测价值[J].安徽医科大学学报,2017,52(8):1192-1195.
[21] 张极星,张艳国,赵亮,等.急性期脑出血患者血清ICAM-1、MMP-9、TNF-α、IL-6水平和出血灶周围水肿脑组织体积的相关性[J].山东医药,2017,57(27):58-60.
[22] 卓奕春.血清神经生长因子和白介素-6水平变化在高血压脑出血患者预后中的价值分析[J].中国医药科学,2021,11(80):186-188,203.
[23] 尹艳霞,尚文俊,郭华,等.轴突生长抑制因子A、核因子-κB p65对急性高血压脑出血患者病情及预后的评估[J].分子诊断与治疗杂志,2020,12(8):1056-1059.
[24] 张茴燕,殷小平.IKK/NF-κB信号通路与中枢神经系统疾病[J].中风与神经疾病杂志,2016,33(12):1143-1145.
[25] 孙婷,陈泉,肖继,等.NF-κB亚基泛素化研究进展[J].生理科学进展,2018,49(3):217-221.
[26] Sun SC.The non-canonical NF-κB pathway in immunity and inflammation [J]. Nat Rev Immunol,2017,17(9):545-558.
[27] 张文琦,张超,田增有,等.脑出血引起继发性炎症反应机制研究进展[J].河北联合大学学报(医学版),2015, 17(4):76-78.
|
|
|
|